Carmine Therapeutics named as one of FierceBiotech’s “Fierce 15” Biotech Companies of 2020
Carmine Therapeutics has been named as one of FierceBiotech’s “Fierce 15” Biotech companies of 2020, designating it as one of the most promi
Carmine Therapeutics named as one of FierceBiotech’s “Fierce 15” Biotech Companies of 2020
Carmine Therapeutics & Takeda Collaborate to Develop Novel Non-viral Gene Therapies
Carmine Therapeutics won the Bristol-Myers Squibb’s 2019 Golden Ticket
Esco Ventures Announces the Launch of Carmine Therapeutics